{
    "clinical_study": {
        "@rank": "45186", 
        "arm_group": [
            {
                "arm_group_label": "Group P: pregnancy w/complications", 
                "description": "The patient is pregnant and has complications typical of placental vascular disease (preeclampsia, eclampsia, HELLP syndrome, retro-placental hematoma, in utero fetal death) or venous thromboembolism (deep vein thrombosis, pulmonary embolism).\n100 patients will be included.\nInterventions to be administered: Bloodwork, baseline"
            }, 
            {
                "arm_group_label": "Group T1: Healthy volunteers", 
                "description": "Healthy volunteers with no history of chronic or neoplastic disease.\n30 healthy volunteers will be included.\nInterventions to be administered: Bloodwork, baseline"
            }, 
            {
                "arm_group_label": "Group T2: Pregnancy, no complications", 
                "description": "Pregnant patients with no identifiable pregnancy complications, and no history of chronic or neoplastic disease.\n50 pregnant volunteers will be included.\nInterventions to be administered: Bloodwork, baseline"
            }, 
            {
                "arm_group_label": "Group T1x: 15 Healthy volunteers", 
                "description": "15 Healthy volunteers randomly selected from group T1.  These patients will have 2 additional months of follow up.\nInterventions to be administered: Blood work, Months 1 & 2"
            }, 
            {
                "arm_group_label": "Group T2x: 15 Pregnancy, no complications", 
                "description": "15 patients randomly selected from group T2; these patients will have 7 months of follow up during pregnancy.\nInterventions to be administered: Bloodwork, Months -1 to -6"
            }
        ], 
        "biospec_descr": {
            "textblock": "At each visit a total of 36 ml of blood will be drawn (5 x EDTA tube = 5 x 4.5ml; 2 x CTAD\n      tube = 2 x 4.5 ml and 1 dry tube = 4.5 ml).\n\n      Tubes will be rapidly conditioned and samples stored at -80\u00b0C. After analysis, remaining\n      samples will be stored in the N\u00eemes University Hospital Biological Collections."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The primary objective of this study is to demonstrate that plasma concentrations of\n      nucleosomes and free DNA differ between three groups:\n\n        1. pregnant patients with complications typical of placental insufficiency or venous\n           thrombosis (group P),\n\n        2. healthy women (Group T1) and\n\n        3. healthy pregnant women (Group T2)."
        }, 
        "brief_title": "Free DNA and Nucleosome Concentrations in Pathological Pregnancies", 
        "completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pregnancy", 
            "Venous Thrombosis", 
            "Pulmonary Embolism", 
            "Hypertension, Pregnancy-Induced", 
            "Eclampsia", 
            "HELLP Syndrome", 
            "Pre-Eclampsia", 
            "Fetal Death", 
            "Placental Insufficiency"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Eclampsia", 
                "Embolism", 
                "Fetal Death", 
                "Hypertension", 
                "Placental Insufficiency", 
                "Pre-Eclampsia", 
                "Pulmonary Embolism", 
                "Thrombosis", 
                "Venous Thrombosis", 
                "Venous Thromboembolism", 
                "HELLP Syndrome", 
                "Hypertension, Pregnancy-Induced"
            ]
        }, 
        "detailed_description": {
            "textblock": "Our secondary objectives include the following:\n\n        1. To describe, in 15 healthy, non-pregnant women changes in plasma concentrations of\n           nucleosomes and free DNA over 3 months.\n\n        2. To describe, in 15 pregnant women (without complications), changes in plasma\n           concentrations of nucleosomes and free DNA over the last 7 months of pregnancy\n\n        3. To show that plasma concentrations of nucleosomes and free DNA, in patients with\n           complicated pregnancies differ according to the nature of the complication\n\n        4. To show that a relationship exists between the concentrations of nucleosomes, free DNA,\n           and total granulocyte microparticles (and trophoblast particles for pregnant women)\n\n        5. To evaluate the relationship between nucleosome concentrations, free DNA concentrations\n           and circulating leukocyte populations\n\n        6. To evaluate the relationship between nucleosome concentrations, free DNA concentrations\n           and hemostasis markers\n\n        7. To describe changes in hemostasis markers throughout pregnancy\n\n        8. To evaluate the relationship between nucleosome concentrations, free DNA concentrations\n           and the angiogenic marker CD146\n\n        9. To add to the N\u00eemes University Hospital biological collections."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria for all patients:\n\n          -  The patient must have given her informed and signed consent\n\n          -  The patient must be insured or beneficiary of a health insurance plan\n\n        Inclusion Criteria for patients in group P:\n\n          -  The patient is pregnant and has complications typical of placental vascular disease\n             (preeclampsia, eclampsia, HELLP syndrome, retro-placental hematoma, in utero fetal\n             death) or venous thromboembolism (deep vein thrombosis, pulmonary embolism)\n\n        Inclusion Criteria for patients in group T1:\n\n          -  The patient is available for 3 months of follow-up\n\n          -  The patient is a non-pregnant healthy volunteer\n\n          -  No identifiable chronic pathologies\n\n          -  No history of neoplastic disease\n\n          -  No history of chronic infectious disease\n\n          -  No acute disease (such as benign infection), now or within the past two weeks\n\n        Inclusion Criteria for patients in group T2:\n\n          -  The patient is available for 7 months of follow-up\n\n          -  The patient is pregnant, with no identifiable pregnancy complications\n\n          -  No identifiable chronic pathologies\n\n          -  No history of neoplastic disease\n\n          -  No history of chronic infectious disease\n\n          -  No acute disease (such as benign infection), now or within the past two weeks\n\n        Exclusion Criteria for all patients:\n\n          -  The patient is participating in another study\n\n          -  The patient is in an exclusion period determined by a previous study\n\n          -  The patient is under judicial protection, under tutorship or curatorship\n\n          -  The patient refuses to sign the consent\n\n          -  It is impossible to correctly inform the patient\n\n          -  The patient cannot read French\n\n          -  The patient is receiving hormonal ovarian stimulation in the context of medically\n             assisted procreation\n\n          -  Impossible to perform venipuncture under good conditions\n\n          -  New complication or pathology during the study (except for pregnancy complications in\n             group P)\n\n        Exclusion Criteria for group T1:\n\n          -  The patient is pregnant\n\n          -  The patient is breast feeding\n\n          -  The patient has given birth within the last 3 months\n\n          -  Known history of chronic disease\n\n          -  History of treated neoplastic disease\n\n          -  Acute disease within the past two weeks (includes benign disease)\n\n        Exclusion Criteria for group T2:\n\n          -  Pregnancy with complications\n\n          -  Known history of chronic disease\n\n          -  History of treated neoplastic disease\n\n          -  Acute disease within the past two weeks (includes benign disease)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The study population includes three groups:\n\n        Group P:  100 pregnant women with complications typical of placental vascular disease or\n        venous thromboembolism.\n\n        Group T1: 30 non-pregnant, healthy volunteers\n\n          -  15 patients will be randomly selected from group T1 to form group T1x. The latter\n             group has two months of additional follow up.\n\n        Group T2:  50 pregnant, healthy volunteers\n\n          -  15 patients will be randomly selected from group T2 to form group T2x. The latter\n             group has 7 months of follow-up during pregnancy."
            }
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01736826", 
            "org_study_id": "LOCAL/2012/SB-01", 
            "secondary_id": "2012-A01273-40"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Group P: pregnancy w/complications", 
                    "Group T1: Healthy volunteers", 
                    "Group T2: Pregnancy, no complications", 
                    "Group T1x: 15 Healthy volunteers", 
                    "Group T2x: 15 Pregnancy, no complications"
                ], 
                "description": "36 ml of blood are drawn at baseline (last month of pregnancy for groups P and T2, inclusion for group T1) in order to quantify the following: plasma free DNA concentration, plasma nucleosome concentration, hemoglobin, platelets, leukocytes, polynuclear neutrophils, mean corpuscular volume, monocytes, mean corpuscular hemoglobin, lymphocytes, polynuclear eosinophils, polynuclear basophils, D-Dimers, Fibrin monomers, Trophoblast microparticles, Angiogenic marker CD146.", 
                "intervention_name": "Bloodwork, baseline", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Group T1x: 15 Healthy volunteers", 
                "description": "36 ml of blood are drawn at 1 & 2 months after inclusion in order to quantify the following: plasma free DNA concentration, plasma nucleosome concentration, hemoglobin, platelets, leukocytes, polynuclear neutrophils, mean corpuscular volume, monocytes, mean corpuscular hemoglobin, lymphocytes, polynuclear eosinophils, polynuclear basophils, D-Dimers, Fibrin monomers, Trophoblast microparticles, Angiogenic marker CD146.", 
                "intervention_name": "Blood work, Months 1 & 2", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Group T2x: 15 Pregnancy, no complications", 
                "description": "36 ml of blood are drawn at the third, fourth, fifth, sixth, seventh and eight months of normal pregnancy (corresponding to months -1 to -6 before comparative baseline; this group is included in the study early during pregnancy)in order to quantify the following: plasma free DNA concentration, plasma nucleosome concentration, hemoglobin, platelets, leukocytes, polynuclear neutrophils, mean corpuscular volume, monocytes, mean corpuscular hemoglobin, lymphocytes, polynuclear eosinophils, polynuclear basophils, D-Dimers, Fibrin monomers, Trophoblast microparticles, Angiogenic marker CD146.", 
                "intervention_name": "Bloodwork, Months -1 to -6", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "plasma nucleosome concentration", 
            "plasma free DNA concentration"
        ], 
        "lastchanged_date": "March 3, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "N\u00eemes Cedex 9", 
                    "country": "France", 
                    "zip": "30029"
                }, 
                "name": "CHU de N\u00eemes - H\u00f4pital Universitaire Car\u00e9meau"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "5", 
        "official_title": "Comparative Study of Plasma Free DNA and Nucleosome Concentrations: Pathological Versus Normal Pregnancies", 
        "overall_contact": {
            "email": "sylvie.bouvier@chu-nimes.fr", 
            "last_name": "Sylvie Bouvier, MD", 
            "phone": "+33.(0)4.66.68.32.11"
        }, 
        "overall_contact_backup": {
            "email": "carey.suehs@chu-nimes.fr", 
            "last_name": "Carey M Suehs, PhD", 
            "phone": "+33.(0)4.66.68.67.88"
        }, 
        "overall_official": [
            {
                "affiliation": "Centre Hospitalier Universitaire de N\u00eemes", 
                "last_name": "Sylvie Bouvier, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Centre Hospitalier Universitaire de N\u00eemes", 
                "last_name": "Eve Mousty, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "France: Committee for the Protection of Personnes", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Total plasma concentration of free DNA (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "Base line (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth", 
                "measure": "Total plasma concentration of nucleosomes (AU)", 
                "safety_issue": "No", 
                "time_frame": "Base line (day 0)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01736826"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Hemoglobin (g/l)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Platelets (g/l)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Leukocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Polynuclear neutrophils(g/l)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Mean corpuscular volume (\u00b5^3)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Monocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Mean corpuscular hemoglobin (pg/GR)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Lymphocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Polynuclear eosinophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Polynuclear basophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "D-dimers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Fibrin monomers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Trophoblast microparticles (%)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group P, baseline occurs within the 30 days preceding birth. For group T1, baseline = time of inclusion. For group T2, baseline occurs within the 30 days preceding birth.", 
                "measure": "Angiogenic marker CD146 (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Hemoglobin (g/l)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Platelets (g/l)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Leukocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Polynuclear neutrophils(g/l)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Mean corpuscular volume (\u00b5^3)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Monocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Mean corpuscular hemoglobin (pg/GR)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Lymphocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Polynuclear eosinophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Polynuclear basophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "D-dimers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Fibrin monomers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Trophoblast microparticles (%)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Angiogenic marker CD146 (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Total plasma concentration of free DNA (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Total plasma concentration of nucleosomes (AU)", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Hemoglobin (g/l)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Platelets (g/l)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Leukocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Polynuclear neutrophils(g/l)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Mean corpuscular volume (\u00b5^3)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Monocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Mean corpuscular hemoglobin (pg/GR)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Lymphocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Polynuclear eosinophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Polynuclear basophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "D-dimers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Fibrin monomers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Trophoblast microparticles (%)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Angiogenic marker CD146 (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Total plasma concentration of free DNA (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T1x only", 
                "measure": "Total plasma concentration of nucleosomes (AU)", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Hemoglobin (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Hemoglobin (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Hemoglobin (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Hemoglobin (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Hemoglobin (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-5 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Hemoglobin (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Platelets (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Platelets (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Platelets (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Platelets (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Platelets (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-5 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Platelets (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Leukocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Leukocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Leukocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Leukocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Leukocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-5 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Leukocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Polynuclear neutrophils(g/l)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Polynuclear neutrophils(g/l)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Polynuclear neutrophils(g/l)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Polynuclear neutrophils(g/l)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Polynuclear neutrophils(g/l)", 
                "safety_issue": "No", 
                "time_frame": "-5 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Polynuclear neutrophils(g/l)", 
                "safety_issue": "No", 
                "time_frame": "-6  months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Mean corpuscular volume (\u00b5^3)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Mean corpuscular volume (\u00b5^3)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Mean corpuscular volume (\u00b5^3)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Mean corpuscular volume (\u00b5^3)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Mean corpuscular volume (\u00b5^3)", 
                "safety_issue": "No", 
                "time_frame": "-5 months"
            }, 
            {
                "description": "For group T2x only", 
                "measure": "Mean corpuscular volume (\u00b5^3)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Monocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Monocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Monocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Monocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Monocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-5 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Monocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Mean corpuscular hemoglobin (pg/GR)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Mean corpuscular hemoglobin (pg/GR)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Mean corpuscular hemoglobin (pg/GR)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Mean corpuscular hemoglobin (pg/GR)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Mean corpuscular hemoglobin (pg/GR)", 
                "safety_issue": "No", 
                "time_frame": "-5  months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Mean corpuscular hemoglobin (pg/GR)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Lymphocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Lymphocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Lymphocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-3  months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Lymphocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-4  months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Lymphocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-5 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Lymphocytes (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Polynuclear eosinophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Polynuclear eosinophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Polynuclear eosinophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Polynuclear eosinophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-4  months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Polynuclear eosinophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-5 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Polynuclear eosinophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Polynuclear basophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Polynuclear basophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Polynuclear basophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Polynuclear basophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Polynuclear basophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-5  months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Polynuclear basophils (g/l)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "D-dimers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "D-dimers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "D-dimers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-3  months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "D-dimers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-4  months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "D-dimers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-5  months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "D-dimers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-6  months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Fibrin monomers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Fibrin monomers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Fibrin monomers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Fibrin monomers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Fibrin monomers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-5  months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Fibrin monomers (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-6  months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Trophoblast microparticles (%)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Trophoblast microparticles (%)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Trophoblast microparticles (%)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Trophoblast microparticles (%)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Trophoblast microparticles (%)", 
                "safety_issue": "No", 
                "time_frame": "-5 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Trophoblast microparticles (%)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Angiogenic marker CD146 (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Angiogenic marker CD146 (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Angiogenic marker CD146 (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Angiogenic marker CD146 (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Angiogenic marker CD146 (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-5 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Angiogenic marker CD146 (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Total plasma concentration of nucleosomes (AU)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Total plasma concentration of nucleosomes (AU)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Total plasma concentration of nucleosomes (AU)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Total plasma concentration of nucleosomes (AU)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Total plasma concentration of nucleosomes (AU)", 
                "safety_issue": "No", 
                "time_frame": "-5 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Total plasma concentration of nucleosomes (AU)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Total plasma concentration of free DNA (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-1 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Total plasma concentration of free DNA (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-2 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Total plasma concentration of free DNA (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-3 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Total plasma concentration of free DNA (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-4 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Total plasma concentration of free DNA (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-5 months"
            }, 
            {
                "description": "For group T2x only.", 
                "measure": "Total plasma concentration of free DNA (ng/ml)", 
                "safety_issue": "No", 
                "time_frame": "-6 months"
            }
        ], 
        "source": "Centre Hospitalier Universitaire de N\u012bmes", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de N\u012bmes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}